BD completes acquisition of Edwards Lifesciences’ Critical Care product group
The $4.2bn all-cash transaction, announced in June 2024, will see the Critical Care product group being renamed as BD Advanced Patient Monitoring.
Patient Monitoring
Leuko secures $4.5m NIH grant to advance blood testing device
MarinHealth Medical Center launches cardiac MRI tool
FDA approves Terumo’s CDI OneView Monitoring System
Vivalink introduces new solution for MCT and Holter monitoring
GE HealthCare’s new vital signs monitor receives FDA 510(k) clearance
Abbott’s insertable cardiac monitor receives CE Mark
Empatica launches EpiMonitor epilepsy monitoring system
